Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long Term Study of Ambrisentan in Pulmonary Arterial Hypertension Subjects Having Completed AMB-320 (NCT00423748) or AMB-321 (NCT00423202)

NCT00578786 is registered in ClinicalTrials.gov with Gilead Sciences as lead sponsor.

NCT NCT00578786
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00578786 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long Term Study of Ambrisentan in Pulmonary Arterial Hypertension Subjects Having Completed AMB-320 (NCT00423748) or AMB-321 (NCT00423202)
Lead sponsor
Gilead Sciences
Phase
Phase 3
Overall status
Completed
Start date
February 29, 2004
Completion date
March 31, 2010
Enrollment
383 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary arterial hypertension